Welcome Investors!

About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP is a renowned securities law firm that is dedicated to protecting the rights of investors. One of our esteemed partners, James (Josh) Wilson, is here to assist investors who have suffered losses in Pacira.

Investigation Against Pacira BioSciences, Inc.

If you purchased or acquired securities in Pacira between August 2, 2023, and August 8, 2024, you may be eligible to seek legal action. Faruqi & Faruqi is currently investigating potential claims against Pacira BioSciences, Inc. (NASDAQ: PCRX). Investors are reminded of the upcoming deadline on March 14, 2025, to seek the role of lead plaintiff in a federal securities class action against the Company.

How Will This Affect You?

As an investor who has suffered losses in Pacira, contacting Faruqi & Faruqi partner Josh Wilson can help you understand and explore your legal options. It is crucial to act promptly and discuss your situation to protect your rights.

How Will This Affect the World?

This investigation against Pacira BioSciences, Inc. highlights the importance of transparency and accountability in the financial markets. Holding companies responsible for any potential wrongdoing sets a precedent for ethical business practices and investor protection.

Conclusion

If you have incurred losses in Pacira, don’t hesitate to reach out to Faruqi & Faruqi for a consultation. Partner Josh Wilson is prepared to assist you in navigating the legal process and seeking justice for your investments. Remember, your voice as an investor matters, and taking action can help uphold integrity in the financial industry.